Effect of 4-Week Consumption of Soy Kori-tofu on Cardiometabolic Health Markers: A Double-Blind Randomized Controlled Cross-Over Trial in Adults with Mildly Elevated Cholesterol Levels
Open Access
Abstract
Kori-tofu is a frozen soy tofu, and soy consumption is associated with positive effects on cardiometabolic health markers. We aimed to assess the potential of Kori-tofu to improve cardiometabolic health outcomes in humans by repetitive daily consumption. In a double-blind randomized controlled cross-over trial, 45 subjects aged 40–70 years with (mildly) elevated cholesterol levels, received a four week Kori-tofu intervention or whey protein control intervention with a four week wash-out period in between. Cardiometabolic biomarkers were measured before and after both interventions. A significant decrease in total, low-density lipids (LDL), and high-density lipids (HDL) cholesterol, Hemoglobin A1c (HbA1c), fructosamine and systolic blood pressure was observed within the Kori-tofu intervention. However, many of these findings were also observed in the control intervention. Only adiponectin changes were different between treatments but did not change significantly within interventions. Improvements in cardiometabolic markers within the Kori-tofu intervention point toward potential beneficial health effects. Due to the lack of significant effects as compared to control, there is, however, currently no substantiating evidence to claim that Kori-tofu has beneficial effects on cardiometabolic health.Keywords
Funding Information
- Asahimatsu Foods Company Limited, Nagano, Japan
This publication has 36 references indexed in Scilit:
- Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trialsThe American Journal of Clinical Nutrition, 2011
- Effect of soya protein on blood pressure: a meta-analysis of randomised controlled trialsBritish Journal of Nutrition, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Beyond Established and Novel Risk FactorsCirculation, 2008
- A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese womenApplied Physiology, Nutrition, and Metabolism, 2007
- HbA1c as a screening tool for detection of Type 2 diabetes: a systematic reviewDiabetic Medicine, 2007
- Treatment of Elevated CholesterolCirculation, 2005
- Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and managementDiabetes & Vascular Disease Research, 2005
- Within-person variation in serum lipids: implications for clinical trialsInternational Journal of Epidemiology, 2004
- Efficacy and Safety of Plant Stanols and Sterols in the Management of Blood Cholesterol LevelsMayo Clinic Proceedings, 2003